North America Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

GlobalData’s “North America Orthobiologics Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

The North America Orthobiologics Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2025 company share data for Orthobiologics Market.
• Global corporate-level profiles of key companies operating within the North America Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Orthobiologics is segmented as follows:

• Cartilage Repair

• Bone Grafts and Substitutes

• Bone Growth Stimulators

• Soft Tissue Biologics

• Viscosupplementation

Reasons to Buy

The North America Orthobiologics Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Medtronic Plc
Sanofi
Bioventus Inc
Stryker Corp
Orthofix Holdings Inc
Zimmer Biomet Holdings Inc
Orthofix Medical Inc
Enovis Corp
Arthrex Inc
Globus Medical Inc
DePuy Synthes Inc
Xtant Medical Holdings Inc
Smith & Nephew Plc
Ferring Pharmaceuticals AS
LifeNet Health Inc
Highridge Inc
CONMED Corp
Fidia farmaceutici SpA
AlloSource
Seikagaku Corp
Anika Therapeutics Inc
Avanos Medical Inc

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Orthobiologics Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Orthobiologics Market, North America

3.1 Orthobiologics Market, North America, Revenue ($m), 2018-2033

3.2 Orthobiologics Market, North America, Revenue ($m), 2018-2033

3.3 Orthobiologics Market, North America, Volume (Units), 2018-2033

3.4 Orthobiologics Market, North America, Volume (Units), 2018-2033

3.5 Orthobiologics Market, North America, Company Share by Revenue ($m), 2025

4 Orthobiologics Market, Canada

4.1 Orthobiologics Market, Canada, Revenue ($m), 2018-2033

4.1.1 Bone Grafts and Substitutes Market, Canada, Revenue ($m), by Segment, 2018-2033

4.1.2 Bone Growth Stimulators Market, Canada, Revenue ($m), by Segment, 2018-2033

4.1.3 Cartilage Repair Market, Canada, Revenue ($m), by Segment, 2018-2033

4.1.4 Soft Tissue Biologics Market, Canada, Revenue ($m), by Segment, 2018-2033

4.1.5 Viscosupplementation Market, Canada, Revenue ($m), by Segment, 2018-2033

4.2 Orthobiologics Market, Canada, Volume (Units), 2018-2033

4.2.1 Bone Grafts and Substitutes Market, Canada, Volume (Units), by Segment, 2018-2033

4.2.2 Bone Growth Stimulators Market, Canada, Volume (Units), by Segment, 2018-2033

4.2.3 Cartilage Repair Market, Canada, Volume (Units), by Segment, 2018-2033

4.2.4 Soft Tissue Biologics Market, Canada, Volume (Units), by Segment, 2018-2033

4.2.5 Viscosupplementation Market, Canada, Volume (Units), by Segment, 2018-2033

4.3 Orthobiologics Market, Canada, Average Price ($), 2018-2033

4.4 Orthobiologics Market, Canada, Company Share by Revenue ($m), 2025

5 Orthobiologics Market, Mexico

5.1 Orthobiologics Market, Mexico, Revenue ($m), 2018-2033

5.1.1 Bone Grafts and Substitutes Market, Mexico, Revenue ($m), by Segment, 2018-2033

5.1.2 Bone Growth Stimulators Market, Mexico, Revenue ($m), by Segment, 2018-2033

5.1.3 Cartilage Repair Market, Mexico, Revenue ($m), by Segment, 2018-2033

5.1.4 Soft Tissue Biologics Market, Mexico, Revenue ($m), by Segment, 2018-2033

5.1.5 Viscosupplementation Market, Mexico, Revenue ($m), by Segment, 2018-2033

5.2 Orthobiologics Market, Mexico, Volume (Units), 2018-2033

5.2.1 Bone Grafts and Substitutes Market, Mexico, Volume (Units), by Segment, 2018-2033

5.2.2 Bone Growth Stimulators Market, Mexico, Volume (Units), by Segment, 2018-2033

5.2.3 Cartilage Repair Market, Mexico, Volume (Units), by Segment, 2018-2033

5.2.4 Soft Tissue Biologics Market, Mexico, Volume (Units), by Segment, 2018-2033

5.2.5 Viscosupplementation Market, Mexico, Volume (Units), by Segment, 2018-2033

5.3 Orthobiologics Market, Mexico, Average Price ($), 2018-2033

5.4 Orthobiologics Market, Mexico, Company Share by Revenue ($m), 2025

6 Orthobiologics Market, United States

6.1 Orthobiologics Market, United States, Revenue ($m), 2018-2033

6.1.1 Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033

6.1.2 Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2018-2033

6.1.3 Cartilage Repair Market, United States, Revenue ($m), by Segment, 2018-2033

6.1.4 Soft Tissue Biologics Market, United States, Revenue ($m), by Segment, 2018-2033

6.1.5 Viscosupplementation Market, United States, Revenue ($m), by Segment, 2018-2033

6.2 Orthobiologics Market, United States, Volume (Units), 2018-2033

6.2.1 Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2018-2033

6.2.2 Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2018-2033

6.2.3 Cartilage Repair Market, United States, Volume (Units), by Segment, 2018-2033

6.2.4 Soft Tissue Biologics Market, United States, Volume (Units), by Segment, 2018-2033

6.2.5 Viscosupplementation Market, United States, Volume (Units), by Segment, 2018-2033

6.3 Orthobiologics Market, United States, Average Price ($), 2018-2033

6.4 Orthobiologics Market, United States, Company Share by Revenue ($m), 2025

7 Overview of Key Companies in North America Orthobiologics Market

7.1 Medtronic Plc

7.1.1 Company Overview

7.2 Sanofi

7.2.1 Company Overview

7.3 Bioventus Inc

7.3.1 Company Overview

7.4 Stryker Corp

7.4.1 Company Overview

7.5 Orthofix Holdings Inc

7.5.1 Company Overview

7.6 Zimmer Biomet Holdings Inc

7.6.1 Company Overview

7.7 Orthofix Medical Inc

7.7.1 Company Overview

7.8 Enovis Corp

7.8.1 Company Overview

7.9 Arthrex Inc

7.9.1 Company Overview

7.10 Globus Medical Inc

7.10.1 Company Overview

7.11 DePuy Synthes Inc

7.11.1 Company Overview

7.12 Xtant Medical Holdings Inc

7.12.1 Company Overview

7.13 Smith & Nephew Plc

7.13.1 Company Overview

7.14 Ferring Pharmaceuticals AS

7.14.1 Company Overview

7.15 LifeNet Health Inc

7.15.1 Company Overview

7.16 Highridge Inc

7.16.1 Company Overview

7.17 CONMED Corp

7.17.1 Company Overview

7.18 Fidia farmaceutici SpA

7.18.1 Company Overview

7.19 AlloSource

7.19.1 Company Overview

7.20 Seikagaku Corp

7.20.1 Company Overview

7.21 Anika Therapeutics Inc

7.21.1 Company Overview

7.22 Avanos Medical Inc

7.22.1 Company Overview

8 Orthobiologics Market Pipeline Products

9 Recent Developments

9.1 Corporate Communications

9.1.1 Nov 25, 2025: SNF Agora Institute at Johns Hopkins Begins Search for Next Director

9.1.2 Nov 21, 2025: Surgeons Collaborate to Treat War Injuries in Ukraine

9.1.3 Nov 21, 2025: Daniel Weiss to Leave Johns Hopkins to Lead Philadelphia Art Museum

9.1.4 Nov 19, 2025: LEM Surgical Completes First U.S. Clinical Procedures

9.1.5 Nov 18, 2025: Alafair Biosciences Announces First Clinical Use of Versacoat Flowable Hydrogel in Foot and Ankle and Hand and Wrist Procedures

9.1.6 Nov 14, 2025: Roots Equity Group Acquires Innovasis Medical and Appoints Matt Stuttle as CEO

9.1.7 Nov 14, 2025: Zavation Medical Products Launches NanoPrime: A New Hybrid Implant Material

9.1.8 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%

9.1.9 Nov 13, 2025: Dr. Marisa Ames Elected President of American Heartworm Society

9.1.10 Nov 12, 2025: Local Research Focuses On Using Novel Cell Therapy To Repair A Common Knee Injury

9.1.11 Nov 07, 2025: Ganesan Appointed Commissioner for the Commission on Dental Accreditation

9.1.12 Nov 06, 2025: Paho Promotes Interregional Cooperation to Strengthen Health Autonomy in Latin America and the Caribbean

9.1.13 Nov 06, 2025: Applications Open For Catalyst And Discovery Awards

9.1.14 Nov 04, 2025: $1M Grant from Maryland Stem Cell Research Fund Supports Adipose Tissue Allograft Therapy for Osteoarthritis

9.1.15 Oct 29, 2025: Regenerative Medicine Also Known As Stem Cell Therapy

9.1.16 Oct 28, 2025: Alira Health Advises Andera Partners On Strategic Investment In Adler Ortho

9.1.17 Oct 25, 2025: Vidal Appointed Head Of Operative Dentistry

9.1.18 Oct 23, 2025: Integrum Announces Organizational Restructuring to Strengthen Its Commercial Focus

9.1.19 Oct 20, 2025: Committee Tasked With Strategic Planning for JHU's Research Core Facilities

9.1.20 Oct 15, 2025: International Writing Program Director Steps Down After 25 Years

9.1.21 Oct 02, 2025: Gimv Invests CHF 28 Million in Spineart

9.1.22 Oct 01, 2025: Johns Hopkins, Other Large Nonprofits To Double Annual Contribution To Baltimore

9.1.23 Sep 23, 2025: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

9.1.24 Sep 23, 2025: DJ Babu Joins Peabody Conservatory Hip-Hop Faculty

9.1.25 Sep 12, 2025: Engineers Develop Mini Microscope for Real-Time Brain Imaging

9.1.26 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed

9.1.27 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio

9.2 Financial Announcements

9.2.1 Jan 07, 2026: Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

9.2.2 Nov 18, 2025: Aurora Spine Corporation Reports Record Third Quarter Financial Results

9.2.3 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%

9.2.4 Nov 13, 2025: SINTX Reports Third Quarter Business Update and Financial Highlights

9.2.5 Nov 06, 2025: Vericel Reports Third Quarter 2025 Financial Results

9.2.6 Oct 30, 2025: Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update November 6, 2025

9.2.7 Oct 23, 2025: Ocugen to Host Webcast on November 5, 2025 to Discuss Business Updates and Financial Results

9.2.8 May 05, 2025: Integra LifeSciences Reports First Quarter 2025 Financial Results

9.2.9 Apr 18, 2025: Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025

9.2.10 Apr 16, 2025: Assure Tech (Hangzhou) Receives CLIA Approval for FaStep Multi-Drug Urine Test Panel

9.3 Government and Public Interest

9.3.1 Mar 03, 2026: Vericel to Present at Multiple Upcoming Investor Conferences

9.3.2 Dec 01, 2025: Integra LifeSciences Leadership to Present at Citi 2025 Global Healthcare Conference

9.3.3 Nov 20, 2025: Ocugen CEO To Present At NobleCon21

9.3.4 Nov 10, 2025: MIMEDX to Participate in Upcoming Investor Conferences

9.3.5 Oct 02, 2025: Ocugen to Present at Industry and Investor Conferences in October 2025

9.3.6 Sep 02, 2025: Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025

9.3.7 Aug 29, 2025: Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences

9.3.8 Aug 08, 2025: Alphatec Holdings to Participate in Upcoming Conferences

9.3.9 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract

9.3.10 Apr 10, 2025: New Study Shows Arima Genomics’ Technology Detects Actionable Cancer Drivers in Solid Tumors Missed by Standard Tests

9.4 Legal And Regulatory

9.4.1 Jun 13, 2025: FDA Approves Immune Checkpoint Inhibitor Drug for Patients With Resectable Locally Advanced Head and Neck Cancer, Backed by Dana-Farber Research

9.4.2 Jun 04, 2025: Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

9.4.3 Apr 15, 2025: Hangzhou SHINING3D Dental Technology Receives 510(K) Clearance For DT20 Denture Base Resin

9.5 Other Significant Developments

9.5.1 Nov 19, 2025: LEM Surgical Completes First U.S. Clinical Procedures

9.5.2 Nov 18, 2025: CurvaFix Expands National Market Access With Premier Inc. for General Orthopedic Trauma Products

9.5.3 Nov 14, 2025: Intrinsic Therapeutics Completes First Endoscopic Barricaid Implantation in Great Lakes Region

9.5.4 Nov 13, 2025: Curiteva Announces Publication of Peer-Reviewed Study in Journal of Biomaterials

9.5.5 Nov 13, 2025: NavJam LLC Forms Global Distribution Partnership with Ruthless Spine

9.5.6 Nov 04, 2025: $1M Grant from Maryland Stem Cell Research Fund Supports Adipose Tissue Allograft Therapy for Osteoarthritis

9.5.7 Nov 03, 2025: SINTX Technologies Launches OsseoSculpt Biologic for SINAPTIC Foot & Ankle System

9.5.8 Oct 23, 2025: Integrum Announces Organizational Restructuring to Strengthen Its Commercial Focus

9.5.9 Oct 08, 2025: Linshom Medical Receives 510(K) Clearance For Continuous Predictive Respiratory Monitoring System (CPRMS)

9.5.10 Oct 03, 2025: HCA HealthONE Pediatric Scoliosis and Spine Program Rebranded

9.5.11 Oct 01, 2025: Elutia Completes Sale of BioEnvelope Business to Boston Scientific for $88 Million

9.5.12 Sep 29, 2025: D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program

9.5.13 Sep 17, 2025: FAU/Baptist Health AI Spine Model Could Transform Back Pain Treatment

9.5.14 Aug 30, 2025: Blood-Pressure Reductions With Baxdrostat in Patients With Uncontrolled or Resistant Hypertension

9.5.15 May 20, 2025: APEX Biologix Enters Exclusive U.S. Distribution Agreement with Bioventus LLC for XCELL PRP System

9.6 Product News

9.6.1 Jan 14, 2026: MTF Biologics and Kolosis BIO Introduce Summit Matrix for Orthopedic and Spinal Surgeries

9.6.2 Nov 19, 2025: LEM Surgical Completes First U.S. Clinical Procedures

9.6.3 Nov 18, 2025: Aurora Spine Corporation Reports Record Third Quarter Financial Results

9.6.4 Nov 18, 2025: CurvaFix Expands National Market Access With Premier Inc. for General Orthopedic Trauma Products

9.6.5 Nov 15, 2025: Zavation Medical Products Announces First Implantations of Varisync ALIF NanoPrime

9.6.6 Nov 14, 2025: Zimmer Biomet Secures FDA Clearance for Enhanced ROSA Knee Robotic Technology

9.6.7 Nov 14, 2025: Intrinsic Therapeutics Completes First Endoscopic Barricaid Implantation in Great Lakes Region

9.6.8 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%

9.6.9 Nov 13, 2025: Implanet Signs Partnership Agreement With 8i Robotics Inc. For Clinical Evaluation Of Robotic Spine Surgery System

9.6.10 Nov 13, 2025: Icotec Receives FDA Clearance for CMORE CT System, Expanding BlackArmor Engineered Carbon/PEEK Technology

9.6.11 Nov 13, 2025: Curiteva Announces Publication of Peer-Reviewed Study in Journal of Biomaterials

9.6.12 Nov 13, 2025: Texas A&M Researchers Discover Key to Regrowing Limbs

9.6.13 Nov 13, 2025: Captiva Spine Receives FDA Clearance for Flat-Panel C-Arm Calibrators and AI-Assisted Registration

9.6.14 Nov 13, 2025: SINTX Reports Third Quarter Business Update and Financial Highlights

9.6.15 Nov 13, 2025: Curiteva Announces Publication of Peer-Reviewed Study in Journal of Biomaterials

9.6.16 Nov 07, 2025: 3D Nerve Maps Enhance Precision in Bone Repair

9.6.17 Nov 04, 2025: RevBio Receives First FDA Approval for Bone Glue to Treat Extremity Fractures

9.6.18 Nov 04, 2025: $1M Grant from Maryland Stem Cell Research Fund Supports Adipose Tissue Allograft Therapy for Osteoarthritis

9.6.19 Nov 03, 2025: EmeTerm Wristband Reduces Postoperative Nausea and Vomiting in Orthopedic Surgeries

9.6.20 Oct 29, 2025: 4-Web Cervical Disc Fusion Study Now Enrolling

9.6.21 Oct 29, 2025: Cooper and Inspira Neuroscience Perform New Jersey’s First Fully Endoscopic Laminectomy

9.6.22 Oct 28, 2025: Zimmer Biomet Receives FDA Breakthrough Designation for Iodine-Treated Total Hip Replacement System

9.6.23 Oct 27, 2025: Aurora Spine Introduces New Biologics Division

9.6.24 Oct 21, 2025: Onkos Surgical Receives FDA Clearance for ELEOS Proximal Tibia with Antibacterial Technology

9.6.25 Oct 21, 2025: Zimmer Biomet Showcases Robotics and Musculoskeletal Innovations at AAHKS Annual Meeting

9.6.26 Oct 21, 2025: Bone Solutions’ Mg OSTEOCRETE and Mg OSTEOINJECT Get FDA Clearance for Pediatric Use

9.6.27 Oct 20, 2025: Biedermann Motech Expands MOSS!MODULARITY Platform with New Product Introductions

9.6.28 Oct 20, 2025: SINTX Technologies Receives FDA Clearance for Sinaptic Foot & Ankle Implant System

9.6.29 Oct 12, 2025: Mesenchymal Stem Cell Therapy For Multiple Sclerosis: Promising Clinical Research Results

9.6.30 Oct 07, 2025: Zimmer Biomet Completes Acquisition of Monogram Technologies

9.6.31 Oct 06, 2025: I2Pure Celebrates Zimmer Biomet's Approval of Iodine-Treated Implant System

9.6.32 Oct 01, 2025: Orthocell Appoints First Distributor For Remplir In Canadian Market

9.6.33 Oct 01, 2025: Bioretec's RemeOs Screw LAG Solid Receives CMS Transitional Pass-Through Payment

9.6.34 Oct 01, 2025: FDA Grants Clearance For Planmed XFI Full-Body Weight-Bearing CT Scanner

9.6.35 Sep 30, 2025: Vivex Biologics Treats First Patient in Restore Trial for Degenerative Disc Disease

9.6.36 Sep 25, 2025: Zimmer Biomet Receives Japan PMDA Approval for Iodine-Treated Total Hip Replacement System

9.6.37 Sep 23, 2025: Arthrex Completes First Case With NanoNeedle Scope

2.0

9.6.38 Sep 18, 2025: Brainlab Secures FDA 510(k) Clearance and Launches Spine Mixed Reality Navigation

9.6.39 Sep 17, 2025: First Touch CMC 1 Prosthesis Implanted in the United States

9.6.40 Sep 17, 2025: FAU/Baptist Health AI Spine Model Could Transform Back Pain Treatment

9.6.41 Sep 12, 2025: Bioretec Provides Update on RemeOs DrillPin Commercialization

9.6.42 Sep 10, 2025: OrthoPediatrics Corp. Completes First Procedures with VerteGlide Spinal Growth Guidance System

9.6.43 Sep 09, 2025: Medline Unite to Introduce Achilles Repair Systems at AOFAS 2025 Meeting

9.6.44 Apr 23, 2025: Assure Tech Receives CLIA Approval for Healcare Panel Dip Test

9.7 Research And Development

9.7.1 Nov 12, 2025: Local Research Focuses On Using Novel Cell Therapy To Repair A Common Knee Injury

9.8 Strategy And Business Planning

9.8.1 Nov 18, 2025: CurvaFix Expands National Market Access With Premier Inc. for General Orthopedic Trauma Products

9.8.2 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%

9.8.3 Nov 13, 2025: NavJam LLC Forms Global Distribution Partnership with Ruthless Spine

9.8.4 Nov 03, 2025: LISI Group Confirms Sale of LISI MEDICAL Division to SK Capital

9.8.5 Oct 28, 2025: Spartan Medical And Diamond Orthopedic Form Strategic Partnership

9.8.6 Oct 28, 2025: Alira Health Advises Andera Partners On Strategic Investment In Adler Ortho

9.8.7 Oct 28, 2025: Scoliosis Research Society Forms New Partnership with EUROSPINE

9.8.8 Oct 20, 2025: Biedermann Motech Expands MOSS!MODULARITY Platform with New Product Introductions

9.8.9 Oct 02, 2025: Gimv Invests CHF 28 Million in Spineart

9.8.10 Oct 01, 2025: Orthocell Appoints First Distributor For Remplir In Canadian Market

9.8.11 Oct 01, 2025: Elutia Completes Sale of BioEnvelope Business to Boston Scientific for $88 Million

9.8.12 Sep 29, 2025: RMTG Partners With BKFC As Official Regenerative Medicine Provider

9.8.13 Sep 17, 2025: Keensight Capital Acquires Majority Stake in Isto Biologics from Thompson Street Capital Partners

10 Appendix

10.1 Research Methodology

10.1.1 Coverage

10.1.2 Secondary Research

10.1.3 Primary Research

10.1.4 Market Modeling and Forecasting

10.1.5 Company Share Analysis

10.1.6 Benchmarking

10.2 GlobalData Consulting

10.3 Contact Us

10.4 Disclaimer

Table

Table 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033

Table 2: Orthobiologics Market, North America, Revenue ($m), USD Constant, 2018-2033

Table 3: Orthobiologics Market, North America, Volume (Units), 2018-2033

Table 4: Orthobiologics Market, North America, Volume (Units), 2018-2033

Table 5: Orthobiologics Market, North America, Company Share by Revenue ($m), 2025

Table 6: Orthobiologics Market, Canada, Revenue ($m), USD Constant, 2018-2033

Table 7: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, 2018-2033

Table 8: Bone Growth Stimulators Market, Canada, Revenue ($m), USD Constant, 2018-2033

Table 9: Cartilage Repair Market, Canada, Revenue ($m), USD Constant, 2018-2033

Table 10: Soft Tissue Biologics Market, Canada, Revenue ($m), USD Constant, 2018-2033

Table 11: Viscosupplementation Market, Canada, Revenue ($m), USD Constant, 2018-2033

Table 12: Orthobiologics Market, Canada, Volume (Units), 2018-2033

Table 13: Bone Grafts and Substitutes Market, Canada, Volume (Units), 2018-2033

Table 14: Bone Growth Stimulators Market, Canada, Volume (Units), 2018-2033

Table 15: Cartilage Repair Market, Canada, Volume (Units), 2018-2033

Table 16: Soft Tissue Biologics Market, Canada, Volume (Units), 2018-2033

Table 17: Viscosupplementation Market, Canada, Volume (Units), 2018-2033

Table 18: Orthobiologics Market, Canada, Average Price ($), 2018-2033

Table 19: Orthobiologics Market, Canada, Company Share by Revenue ($m), 2025

Table 20: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Table 21: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Table 22: Bone Growth Stimulators Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Table 23: Cartilage Repair Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Table 24: Soft Tissue Biologics Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Table 25: Viscosupplementation Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Table 26: Orthobiologics Market, Mexico, Volume (Units), 2018-2033

Table 27: Bone Grafts and Substitutes Market, Mexico, Volume (Units), 2018-2033

Table 28: Bone Growth Stimulators Market, Mexico, Volume (Units), 2018-2033

Table 29: Cartilage Repair Market, Mexico, Volume (Units), 2018-2033

Table 30: Soft Tissue Biologics Market, Mexico, Volume (Units), 2018-2033

Table 31: Viscosupplementation Market, Mexico, Volume (Units), 2018-2033

Table 32: Orthobiologics Market, Mexico, Average Price ($), 2018-2033

Table 33: Orthobiologics Market, Mexico, Company Share by Revenue ($m), 2025

Table 34: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 35: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 36: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 37: Cartilage Repair Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 38: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 39: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 40: Orthobiologics Market, United States, Volume (Units), 2018-2033

Table 41: Bone Grafts and Substitutes Market, United States, Volume (Units), 2018-2033

Table 42: Bone Growth Stimulators Market, United States, Volume (Units), 2018-2033

Table 43: Cartilage Repair Market, United States, Volume (Units), 2018-2033

Table 44: Soft Tissue Biologics Market, United States, Volume (Units), 2018-2033

Table 45: Viscosupplementation Market, United States, Volume (Units), 2018-2033

Table 46: Orthobiologics Market, United States, Average Price ($), 2018-2033

Table 47: Orthobiologics Market, United States, Company Share by Revenue ($m), 2025

Table 48: Orthobiologics Market Pipeline Products

Table 49: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

Figures

Figure 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033

Figure 2: Orthobiologics Market, North America, Revenue ($m), USD Constant, 2018-2033

Figure 3: Orthobiologics Market, North America, Volume (Units), 2018-2033

Figure 4: Orthobiologics Market, North America, Volume (Units), 2018-2033

Figure 5: Orthobiologics Market, North America, Company Share (%), 2025

Figure 6: Orthobiologics Market, Canada, Revenue ($m), USD Constant, 2018-2033

Figure 7: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, 2018-2033

Figure 8: Bone Growth Stimulators Market, Canada, Revenue ($m), USD Constant, 2018-2033

Figure 9: Cartilage Repair Market, Canada, Revenue ($m), USD Constant, 2018-2033

Figure 10: Soft Tissue Biologics Market, Canada, Revenue ($m), USD Constant, 2018-2033

Figure 11: Viscosupplementation Market, Canada, Revenue ($m), USD Constant, 2018-2033

Figure 12: Orthobiologics Market, Canada, Volume (Units), 2018-2033

Figure 13: Bone Grafts and Substitutes Market, Canada, Volume (Units), 2018-2033

Figure 14: Bone Growth Stimulators Market, Canada, Volume (Units), 2018-2033

Figure 15: Cartilage Repair Market, Canada, Volume (Units), 2018-2033

Figure 16: Soft Tissue Biologics Market, Canada, Volume (Units), 2018-2033

Figure 17: Viscosupplementation Market, Canada, Volume (Units), 2018-2033

Figure 18: Orthobiologics Market, Canada, Company Share (%), 2025

Figure 19: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Figure 20: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Figure 21: Bone Growth Stimulators Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Figure 22: Cartilage Repair Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Figure 23: Soft Tissue Biologics Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Figure 24: Viscosupplementation Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Figure 25: Orthobiologics Market, Mexico, Volume (Units), 2018-2033

Figure 26: Bone Grafts and Substitutes Market, Mexico, Volume (Units), 2018-2033

Figure 27: Bone Growth Stimulators Market, Mexico, Volume (Units), 2018-2033

Figure 28: Cartilage Repair Market, Mexico, Volume (Units), 2018-2033

Figure 29: Soft Tissue Biologics Market, Mexico, Volume (Units), 2018-2033

Figure 30: Viscosupplementation Market, Mexico, Volume (Units), 2018-2033

Figure 31: Orthobiologics Market, Mexico, Company Share (%), 2025

Figure 32: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 33: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 34: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 35: Cartilage Repair Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 36: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 37: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 38: Orthobiologics Market, United States, Volume (Units), 2018-2033

Figure 39: Bone Grafts and Substitutes Market, United States, Volume (Units), 2018-2033

Figure 40: Bone Growth Stimulators Market, United States, Volume (Units), 2018-2033

Figure 41: Cartilage Repair Market, United States, Volume (Units), 2018-2033

Figure 42: Soft Tissue Biologics Market, United States, Volume (Units), 2018-2033

Figure 43: Viscosupplementation Market, United States, Volume (Units), 2018-2033

Figure 44: Orthobiologics Market, United States, Company Share (%), 2025

North America Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation standard reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation in real time.

  • Access a live North America Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.